2004). These effects show that ginsenoside Rg3 shields neurons in vitro from NMDA-induced neurotoxicity and in vivo ginsenoside Rh2 guards from ischemia-reperfusion brain harm. The neuroprotective action of such ginsenosides is usually attributed to the specific inhibition of NMDA-induced receptor activation.Raltegravir has become affiliated with l